Alopecia Areata: Patchy Hair Loss and Where to Find Support
Understand patchy hair loss, assessment, current treatment discussions and practical and emotional support for alopecia areata.
Finding a new patch of hair loss can be unsettling, particularly when the skin underneath looks relatively normal. Alopecia areata is one possible cause, but patchy loss should be assessed rather than diagnosed from an online photograph.
If alopecia areata is confirmed, care can include discussion of treatment, scalp and eye comfort, wigs or camouflage, and emotional support. The effect on your daily life matters even when the area of hair loss appears small to somebody else.
Key takeaways
- Alopecia areata involves immune activity affecting hair follicles and is not contagious.
- It can affect scalp hair, facial hair or other body hair.
- Regrowth is possible, but timing and future episodes are unpredictable.
- Treatment depends on age, extent, location and individual circumstances.
- Support and practical choices deserve attention alongside regrowth.
On this page
What alopecia areata means
The British Association of Dermatologists describes alopecia areata as non-scarring hair loss: the follicles are not permanently destroyed, so hair can potentially regrow. It often appears as round patches, but may affect larger areas. Loss of all scalp hair is called alopecia totalis; involvement of hair across the body is called alopecia universalis.
The immune system mistakenly targets the follicles. The exact triggers are not fully understood, and genetic susceptibility can play a part. It is not something you catch from another person. Avoid assuming that a particular food, stressful week or personal failing explains why it happened.
Not all hair loss has this mechanism. Gradual patterned thinning, discussed in our male pattern hair loss guide, and diffuse shedding require different assessments. Sharing a symptom does not make treatments interchangeable.
What to take to an appointment
Write down when you first noticed the change, whether further areas appeared and whether there are scalp symptoms. Mention changes to eyebrows, eyelashes, body hair or nails, and bring a medicine list and relevant personal or family health history.
The American Academy of Dermatology explains that assessment may include examination of hair and nails, sometimes with a magnifying instrument. Tests or a biopsy may be used when needed; they are not automatically required for every person. Ask what question a proposed test is intended to answer.
Photographs can help establish the sequence, particularly if areas have changed before the appointment. Keep them private, unfiltered and clearly dated. A brief timeline is often easier to discuss than a large collection of daily images with different lighting.
| Topic | Useful information | Question to ask |
|---|---|---|
| Pattern and timing | First patch, progression and any regrowth | Does the examination support alopecia areata? |
| Other affected areas | Eyebrows, lashes, beard, body hair or nails | Does this change care or assessment? |
| Comfort | Scalp or eye symptoms and product reactions | What practical protection is appropriate? |
| Wellbeing | Work, school, sleep, confidence and social impact | What support can be arranged? |
Regrowth and uncertainty
Some people regrow hair without treatment, while others experience persistent or extensive loss. Further episodes can occur after regrowth. The British Association of Dermatologists emphasises that there is currently no cure, so a treatment that encourages growth should not be described as permanently eliminating the condition.
This uncertainty can make waiting difficult. Ask for an agreed follow-up plan even if observation is chosen. Clarify what changes should prompt an earlier appointment and how you can raise concerns between reviews. Observation should still leave you with an understandable route back to care.
Discuss what would count as a meaningful improvement for you. Scalp coverage, eyebrow regrowth and reduced worry are different outcomes. A scalp-hair score used in a study does not capture all of them, and a treatment decision should acknowledge that distinction.
How treatment choices are made
The AAD describes several possible approaches, including observation, corticosteroids applied to affected skin or injected by a clinician, and specialist treatments for more extensive disease. Choice depends on age, location, extent and other factors. There is no one treatment that works for everyone.
Ask about the intended benefit, evidence, likely burdens and adverse effects of the specific option offered. For a clinic-based treatment, consider appointment frequency and travel. For a medicine, ask how response and safety will be monitored, who issues continuing prescriptions and when the decision to continue is reviewed.
Do not apply a product licensed for patterned scalp hair loss to eyebrows or eyelashes without specialist instructions. The eye area requires particular care. An online routine describing a different condition or another country’s prescribing practice is not a substitute for your treatment plan.
Newer medicines need current, local advice
NICE’s 2024 appraisal recommends ritlecitinib as an option for severe alopecia areata in people aged 12 and over, within its marketing authorisation and commercial arrangement. That is a specific recommendation, not an indication that every patch of hair loss needs this medicine.
In 2026, Alopecia UK reported NICE’s recommendation of deuruxolitinib for adults with severe alopecia areata and published updated access advice. Availability, individual eligibility and the prescribing pathway should be checked with the specialist service. UK nations can have different appraisal and service arrangements, so a news headline is not enough to establish your access.
These medicines require a discussion of suitability, relevant risks and monitoring. Ask what pre-treatment checks are needed, how ongoing safety is reviewed and what happens if treatment does not help. Do not use an older leaflet’s list of options as though it were a complete account of current availability.
Practical support is part of care
You may want a wig, head covering, camouflage, a different hairstyle or none of these. There is no single correct way to respond. Ask the clinical team about local wig services, eligibility and any contribution required rather than assuming that all provision is identical.
Alopecia UK runs peer-support groups and provides information about living with hair loss. Check the intended age group and current meeting arrangements before joining. Peer support can offer shared experience; treatment decisions still belong with qualified healthcare professionals who know your circumstances.
If hair loss affects mood, sleep, relationships or attendance at work or school, explain that directly to your GP or specialist. Our guide to planning a dermatology appointment includes practical questions about consultations and follow-up for people considering private care.
Keep the plan centred on your priorities
Describe the pattern, symptoms and impact, with examination or tests where needed.
Consider observation, treatment and practical support with realistic expectations.
Agree how changes, safety and wellbeing will be followed up.
Common questions
Does every bald patch mean alopecia areata?
No. Several conditions can cause patchy loss. An examination helps establish the cause, especially when there is scaling, pain or another unexpected symptom.
Is it contagious?
No. Alopecia areata involves immune activity affecting follicles. It does not spread through contact with another person.
Did stress cause my hair loss?
The triggers are not fully understood, and a clear cause often cannot be identified. Avoid blaming yourself. Support for stress can still be valuable without claiming it will cure the hair loss.
Will my hair grow back?
Regrowth is possible, but the amount and timing vary, and recurrence can occur. Ask your clinician how the pattern and extent inform your individual discussion.
Do I need blood tests?
Not everyone needs the same investigations. Ask what the history and examination suggest, and what a proposed test would change about the diagnosis or care plan.
Are JAK inhibitors suitable for a small isolated patch?
The cited NICE recommendations concern severe disease. Suitability and eligibility require specialist assessment; a new medicine’s availability does not mean it is appropriate for every presentation.
Can I get help with a wig?
Ask your clinical team about local services and funding arrangements. Provision and contributions vary, so obtain current information for your location and circumstances.
Is it reasonable to seek support before deciding on treatment?
Yes. You do not need to wait for a treatment decision or extensive hair loss to discuss its emotional impact or seek appropriate peer and professional support.
Sources and further reading
Sources checked 21 October 2026. NICE ritlecitinib recommendations were reviewed through indexed primary text; the 2026 access update is attributed to Alopecia UK. Clinical review is not claimed.
Keep exploring
Anti-Dandruff Shampoo Ingredients: What to Ask a Pharmacist
Ask a pharmacist about dandruff shampoo ingredients, contact time and hair texture, and recognise when persistent scalp symptoms need assessment.
Caring for Curly and Coily Hair While Protecting the Scalp
Build a manageable curly or coily hair routine with gentle detangling, scalp cleansing, lower-tension styling and advice on when to seek assessment.
Clarifying Shampoos: Product Build-Up, Uses and Irritation Risks
Decide whether clarifying shampoo fits your routine, distinguish residue from scalp symptoms and avoid unnecessary cleansing or irritation.
Heat Styling and Hair Damage: A Practical Care Guide
Review heat settings, repeated styling and combined processing, with practical ways to reduce hair damage and recognise concerns needing assessment.